Multiple Myeloma | Oncology Today with Dr Neil Love: BCMA-Directed Therapies for Multiple Myeloma (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Amrita Krishnan, including the following topics: Key efficacy and safety data with belantamab mafodotin for multiple myeloma (MM) (0:00) Guidelines for the prevention and management of keratopathy in patients receiving belantamab mafodotin (3:46) Belantamab mafodotin in combination with pomalidomide; recent data and ongoing trials with BCMA-targeted bispecific antibodies (7:30) BCMA-targeted CAR (chimeric antigen receptor) T-cell therapies under evaluation for MM (17:07) CME information and select publications